| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
38,748 |
35,845 |
$2.25M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
29,358 |
25,814 |
$1.37M |
| K1034 |
Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count |
18,016 |
13,478 |
$945K |
| 99215 |
Prolong outpt/office vis |
9,373 |
8,746 |
$699K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
9,683 |
9,186 |
$666K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
11,819 |
10,914 |
$403K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
7,154 |
6,690 |
$366K |
| 99205 |
Prolong outpt/office vis |
4,283 |
4,130 |
$318K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
10,417 |
9,642 |
$168K |
| 86328 |
|
5,313 |
4,806 |
$161K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
11,526 |
10,868 |
$117K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
11,398 |
8,034 |
$116K |
| 99051 |
|
5,740 |
5,422 |
$68K |
| A4927 |
Gloves, non-sterile, per 100 |
10,419 |
9,419 |
$55K |
| 87400 |
|
6,134 |
5,769 |
$40K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,537 |
3,185 |
$39K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
685 |
610 |
$19K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
527 |
486 |
$15K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
176 |
169 |
$13K |
| 99201 |
|
529 |
473 |
$8K |
| 87807 |
|
578 |
553 |
$7K |
| 81025 |
|
1,061 |
1,028 |
$5K |
| 81000 |
|
683 |
654 |
$4K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
315 |
304 |
$3K |
| 86769 |
|
129 |
123 |
$3K |
| A4930 |
Gloves, sterile, per pair |
12,317 |
11,224 |
$3K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
85 |
76 |
$3K |
| 81002 |
|
1,314 |
1,258 |
$3K |
| A4250 |
Urine test or reagent strips or tablets (100 tablets or strips) |
3,038 |
2,909 |
$3K |
| 86308 |
|
856 |
825 |
$2K |
| S9083 |
Global fee urgent care centers |
12,580 |
11,503 |
$2K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
61 |
60 |
$2K |
| P9615 |
Catheterization for collection of specimen(s) (multiple patients) |
354 |
344 |
$2K |
| 81005 |
|
1,135 |
1,087 |
$1K |
| 3210F |
|
120 |
116 |
$1K |
| A4620 |
Variable concentration mask |
2,197 |
1,861 |
$906.18 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
847 |
771 |
$892.43 |
| 87634 |
|
25 |
25 |
$857.95 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
65 |
56 |
$843.00 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
49 |
49 |
$782.62 |
| 86664 |
|
80 |
75 |
$773.44 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
533 |
460 |
$661.10 |
| 86403 |
|
95 |
88 |
$589.58 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
162 |
120 |
$468.84 |
| 94761 |
|
127 |
122 |
$415.79 |
| 87535 |
|
84 |
78 |
$387.74 |
| 94664 |
|
46 |
44 |
$384.58 |
| 36415 |
Collection of venous blood by venipuncture |
105 |
90 |
$291.20 |
| A4232 |
Syringe with needle for external insulin pump, sterile, 3 cc |
95 |
84 |
$224.71 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
12 |
12 |
$174.15 |
| 81099 |
|
56 |
56 |
$154.31 |
| A4928 |
Surgical mask, per 20 |
15,174 |
13,917 |
$151.09 |
| 99072 |
|
4,844 |
4,441 |
$148.56 |
| 99070 |
|
20,892 |
19,277 |
$147.50 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
20 |
20 |
$101.50 |
| A4208 |
Syringe with needle, sterile 3 cc, each |
569 |
521 |
$94.31 |
| 86663 |
|
12 |
12 |
$78.99 |
| S9088 |
Services provided in an urgent care center (list in addition to code for service) |
5,408 |
4,979 |
$58.80 |
| A4215 |
Needle, sterile, any size, each |
1,268 |
1,154 |
$31.14 |
| A4320 |
Irrigation tray with bulb or piston syringe, any purpose |
176 |
167 |
$22.50 |
| 94760 |
|
21,349 |
19,461 |
$22.03 |
| 99000 |
|
14,246 |
13,331 |
$21.55 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
12 |
12 |
$0.52 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
104 |
73 |
$0.33 |
| A4258 |
Spring-powered device for lancet, each |
122 |
114 |
$0.00 |
| 99058 |
|
13 |
12 |
$0.00 |
| Q3014 |
Telehealth originating site facility fee |
56 |
45 |
$0.00 |
| 94762 |
|
24 |
21 |
$0.00 |
| 99071 |
|
21 |
19 |
$0.00 |
| A4606 |
Oxygen probe for use with oximeter device, replacement |
25 |
25 |
$0.00 |
| 99001 |
|
13 |
13 |
$0.00 |
| A4206 |
Syringe with needle, sterile, 1 cc or less, each |
16 |
16 |
$0.00 |